Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
16 results
  • Ovarian Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Esophageal Cancer, Lung Cancer

22-281          Phase I

A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of Second Mitochondrial-derived Activator of Caspases Mimetic BGB-24714 as Monotherapy and in Combination With Chemotherapy in Patients With Advanced or Metastatic Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Gastric (Stomach) Cancer, Esophageal Cancer, Colorectal Cancer, Breast Cancer, Ovarian Cancer

22-235          Phase I

A Phase 1, Open-Label, Multicenter, Dose Escalation Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of IMM2902 in Patients with HER2-Expressing Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Metastatic/Advanced Cancer, Lung Cancer, Liver Cancer, Gastric (Stomach) Cancer, Esophageal Cancer, Brain Tumors, Metastatic

19-812          Phase I

A Phase 1, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0022, a novel MET/CSF1R/SRC inhibitor, in Patients with Advanced Solid Tumors Harboring Genetic Alterations in MET (View details on clinicaltrial.gov)

  • Sarcoma, Bladder Cancer, Liver Cancer, Gastric (Stomach) Cancer, Endometrial Cancer, Esophageal Cancer, Pancreatic Cancer

20-544          Phase II

A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Advanced Solid Tumors Harboring a p53 Y220C Mutation (View details on clinicaltrial.gov)

  • Endometrial Cancer, Cervical Cancer, Breast Cancer, Pancreatic Cancer, Ovarian Cancer, Lung Cancer, Head and Neck Cancer, Gastric (Stomach) Cancer, Esophageal Cancer

22-015          Phase I

A Phase 1a/1b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY159 as a SA and In Combination with Pembrolizumab in Subjects with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Gastric (Stomach) Cancer, Esophageal Cancer

22-253          Phase II

A Phase 2 Trial to Evaluate the Safety and Efficacy of Domvanalimab (AB154) and Zimberelimab (AB122) -Based Treatment Combinations in Patients with Advanced Upper Gastrointestinal Tract Malignancies (View details on clinicaltrial.gov)

  • Gastric (Stomach) Cancer, Esophageal Cancer

20-433          Phase II

A Phase 2a, Multicenter, Open-Label Study of DKN-01 in Combination with Tislelizumab +/-Chemotherapy as First- Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Distinguish) (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Esophageal Cancer, Lung Cancer, Kidney Cancer

22-571          Phase I

A phase I/Ib, open-label, multi-center, study of QEQ278 in patients with advanced solid tumors (View details on clinicaltrial.gov)

  • Gastric (Stomach) Cancer, Head and Neck Cancer, Esophageal Cancer, Lung Cancer, Colorectal Cancer

19-431          Phase I

A Phase Ib, open-label, multi-center study to characterize the safety, tolerability, and preliminary efficacy of TNO155 in combination with spartalizumab or ribociclib in selected malignancies (View details on clinicaltrial.gov)

Showing 1 - 10 of 16 results